Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.53B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Stoke Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
3 insiders, $1.26M in total
Insiders trading
3
Net value
−$1.26M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Stoke Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Stoke Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Cumbo AlexanderDirector–Sep 25, 20261
Ticho BarryCHIEF MEDICAL OFFICER20,110Sep 3, 202614
Kaye Edward M. MDDirector124,557Aug 18, 20268
Allan JonathanGENERAL COUNSEL & CORP SEC21,225Aug 18, 202610
Harrison Seth LoringDirector–Jul 17, 20262
McCauley ThomasChief Scientific Officer–Jul 17, 20261
Levin Arthur ADirector4,237Jun 5, 20264
Smith JulieDirector–Jun 5, 20261
Tzianabos ArthurDirector31,339Jun 5, 20262
Burstein JenniferDirector–Jun 5, 20261
Krainer Adrian R.Director283,302Jun 5, 20265
Kahn ClareDirector–Apr 7, 20261
Hoitt JasonChief Patient Officer10,276Mar 19, 20263
Leggett ThomasChief Financial Officer10,172Mar 19, 20263
Smith Ian FChief Executive Officer–Feb 19, 20262
Ezbon International Ltd10% Owner3,906,181IndirectJun 6, 20250
Blue Horizon Enterprise Ltd10% Owner3,906,181IndirectJun 6, 20250
Montrago Trustees Ltd10% Owner3,906,181IndirectJun 6, 20250
Skorpios Trust10% Owner3,906,181IndirectJun 6, 20250
Menzel Garry EDirector–Jun 4, 20250
Nash Huw M.Chief Business Officer0Jul 3, 20240
Tulipano Stephen JFormer CFO20,746Jun 7, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 3, 2026 (view filing)4:17 PM ETSep 12 daysTicho BarryCHIEF MEDICAL OFFICERSSale−5.54K$30.67−$170.1K−21.6%20.1K after2 lots10b5-1
Aug 18, 2026 (view filing)8:29 PM ETAug 18Same dayTicho BarryCHIEF MEDICAL OFFICERSSale−4.77K$32.03−$152.7K−15.7%25.7K after2 lots
Aug 18, 2026 (view filing)8:28 PM ETAug 18Same dayKaye Edward M. MDDirectorSSale−12.6K$32.03−$402.5K−9.2%124.6K after2 lots
Aug 18, 2026 (view filing)8:27 PM ETAug 18Same dayAllan JonathanGENERAL COUNSEL & CORP SECSSale−2.86K$32.03−$91.6K−11.9%21.2K after2 lots
Aug 5, 2026 (view filing)4:17 PM ETAug 32 daysTicho BarryCHIEF MEDICAL OFFICERSSale−7.18K$29.04−$208.4K−26.0%20.4K after2 lots10b5-1
Jul 6, 2026 (view filing)4:10 PM ETJul 15 daysTicho BarryCHIEF MEDICAL OFFICERSSale−7.23K$32.66−$236.1K−20.8%27.6K after2 lots10b5-1
Jun 18, 2026 (view filing)Jun 162 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−1.46K$29.95−$43.6K−7.5%18.1K after10b5-1
Jun 3, 2026 (view filing)Jun 12 daysTicho BarryCHIEF MEDICAL OFFICERSSale−1.79K$30.58−$54.9K−4.9%34.8K after10b5-1
May 5, 2026 (view filing)May 14 daysTicho BarryCHIEF MEDICAL OFFICERSSale−2.24K$32.79−$73.5K−5.8%36.6K after10b5-1
Apr 3, 2026 (view filing)Apr 12 daysTicho BarryCHIEF MEDICAL OFFICERSSale−1.84K$32.66−$60.0K−4.5%38.9K after10b5-1
Mar 24, 2026 (view filing)Mar 204 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−9.29K$33.69−$313.1K−32.2%19.5K after2 lots10b5-1
Mar 19, 2026 (view filing)Mar 17-182 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−8.89K$32.14−$285.9K−23.6%28.8K after5 lots
Mar 19, 2026 (view filing)Mar 17-192 daysTicho BarryCHIEF MEDICAL OFFICERSSale−14.3K$31.92−$456.8K−26.0%40.7K after6 lots10b5-1
Mar 19, 2026 (view filing)Mar 17-182 daysLeggett ThomasChief Financial OfficerSSale−4.58K$32.14−$147.1K−31.0%10.2K after5 lots
Mar 19, 2026 (view filing)Mar 17-182 daysHoitt JasonChief Patient OfficerSSale−3.71K$32.14−$119.3K−26.5%10.3K after5 lots
Mar 17, 2026 (view filing)Mar 134 daysLevin Arthur ADirectorSSale−605$36.80−$22.3K−12.5%4.24K after10b5-1
Mar 12, 2026 (view filing)Mar 102 daysKrainer Adrian R.DirectorSSale−33.2K$39.74−$1.32M−10.5%283.3K after10b5-1
Mar 12, 2026 (view filing)Mar 102 daysTzianabos ArthurInterim Executive ChairSSale−4.36K$40.00−$174.2K−12.2%31.3K after10b5-1
Mar 4, 2026 (view filing)Mar 22 daysKrainer Adrian R.DirectorSSale−7.23K$39.66−$286.7K−2.2%316.5K after10b5-1
Dec 10, 2025 (view filing)Dec 82 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−3.98K$32.28−$128.4K−25.2%11.8K after2 lots10b5-1
Dec 10, 2025 (view filing)Dec 82 daysKaye Edward M. MDDirectorSSale−13.4K$32.27−$433.4K−21.5%49.1K after3 lots10b5-1
Dec 5, 2025 (view filing)Dec 4-51 dayAllan JonathanGENERAL COUNSEL & CORP SECSSale−9.80K$31.25−$306.3K−38.3%15.8K after5 lots10b5-1
Dec 5, 2025 (view filing)Dec 4-51 dayTicho BarryCHIEF MEDICAL OFFICERSSale−5.36K$31.19−$167.1K−21.3%19.8K after4 lots10b5-1
Dec 5, 2025 (view filing)Dec 4-51 dayKaye Edward M. MDDirectorSSale−15.0K$31.13−$466.9K−19.3%62.6K after5 lots10b5-1
Dec 3, 2025 (view filing)Dec 2-31 dayAllan JonathanGENERAL COUNSEL & CORP SECSSale−4.58K$30.22−$138.3K−18.9%19.6K after4 lots
Dec 3, 2025 (view filing)Dec 2-31 dayTicho BarryCHIEF MEDICAL OFFICERSSale−4.02K$30.22−$121.5K−21.0%15.2K after4 lots
Dec 3, 2025 (view filing)Dec 2-31 dayKaye Edward M. MDDirectorSSale−2.14K$30.22−$64.5K−4.0%51.3K after4 lots
Nov 26, 2025 (view filing)Nov 242 daysKrainer Adrian R.DirectorSSale−40.5K$29.72−$1.20M−11.1%323.8K after10b5-1
Nov 18, 2025 (view filing)Nov 144 daysKrainer Adrian R.DirectorSSale−40.5K$26.98−$1.09M−10.0%364.2K after2 lots10b5-1
Nov 5, 2025 (view filing)Nov 32 daysTicho BarryCHIEF MEDICAL OFFICERSSale−5.93K$25.72−$152.5K−45.2%7.20K after4 lots10b5-1
Oct 10, 2025 (view filing)Oct 82 daysKaye Edward M. MDDirectorSSale−25.0K$30.00−$750.0K−33.7%49.1K after10b5-1
Oct 7, 2025 (view filing)Oct 34 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−10.0K$25.07−$250.7K−45.8%11.8K after10b5-1
Oct 7, 2025 (view filing)Oct 34 daysKaye Edward M. MDDirectorSSale−42.5K$25.09−$1.07M−46.4%49.1K after10b5-1
Oct 3, 2025 (view filing)Oct 12 daysTicho BarryCHIEF MEDICAL OFFICERSSale−5.34K$23.64−$126.3K−28.9%13.1K after10b5-1
Sep 3, 2025 (view filing)Sep 21 dayTicho BarryCHIEF MEDICAL OFFICERSSale−5.50K$19.87−$109.3K−22.9%18.5K after10b5-1
Sep 3, 2025 (view filing)Aug 29-Sep 35 daysKaye Edward M. MDDirectorSSale−61.9K$20.13−$1.25M−40.3%91.6K after3 lots10b5-1
Sep 3, 2025 (view filing)Aug 29-Sep 35 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−22.1K$20.11−$444.9K−65.1%11.8K after3 lots10b5-1
Aug 20, 2025 (view filing)Aug 182 daysTicho BarryCHIEF MEDICAL OFFICERSSale−2.81K$18.24−$51.2K−10.5%24.0K after
Aug 20, 2025 (view filing)Aug 182 daysKaye Edward M. MDDirectorSSale−12.1K$18.24−$221.2K−7.3%153.5K after
Aug 20, 2025 (view filing)Aug 182 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−1.68K$18.24−$30.7K−6.6%23.9K after
Aug 15, 2025 (view filing)Aug 132 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−13.7K$15.00−$205.7K−41.1%19.6K after10b5-1
Aug 5, 2025 (view filing)Aug 14 daysTicho BarryCHIEF MEDICAL OFFICERSSale−4.50K$12.82−$57.7K−21.2%16.8K after10b5-1
Jul 2, 2025 (view filing)Jul 11 dayTicho BarryCHIEF MEDICAL OFFICERSSale−4.50K$11.63−$52.4K−17.5%21.3K after10b5-1
Jun 6, 2025 (view filing)4:20 PM ETJun 42 daysEzbon International Ltd and 3 others10% OwnerSSale−3.00M$10.20−$30.6M−43.4%3.91M after
Jun 4, 2025 (view filing)Jun 2-32 daysTicho BarryCHIEF MEDICAL OFFICERSSale−8.22K$10.02−$82.4K−24.2%25.8K after2 lots10b5-1
May 5, 2025 (view filing)May 1-24 daysTicho BarryCHIEF MEDICAL OFFICERSSale−26.6K$10.03−$267.0K−43.9%34.0K after2 lots10b5-1
Mar 20, 2025 (view filing)Mar 18-192 daysKaye Edward M. MDDirectorSSale−19.3K$8.49−$163.7K−12.2%139.3K after2 lots
Mar 20, 2025 (view filing)Mar 18-192 daysTicho BarryCHIEF MEDICAL OFFICERSSale−7.22K$8.49−$61.2K−10.6%60.6K after2 lots
Mar 20, 2025 (view filing)Mar 18-192 daysAllan JonathanGENERAL COUNSEL & CORP SECSSale−4.21K$8.49−$35.7K−11.8%31.6K after2 lots
Dec 27, 2024 (view filing)5:13 PM ETDec 234 daysEzbon International Ltd and 3 others10% OwnerSSale−2.00M$11.50−$23.0M−22.5%6.91M after